Literature DB >> 22015442

Validating a case definition for chronic kidney disease using administrative data.

Paul E Ronksley1, Marcello Tonelli, Hude Quan, Braden J Manns, Matthew T James, Fiona M Clement, Susan Samuel, Robert R Quinn, Pietro Ravani, Sony S Brar, Brenda R Hemmelgarn.   

Abstract

BACKGROUND: Administrative data are commonly used for surveillance of chronic medical conditions. The purpose of this study was to determine the validity of an algorithm derived from administrative data for identifying chronic kidney disease (CKD) compared to the reference standard of estimated glomerular filtration rate (eGFR).
METHODS: We identified adults from the province of Alberta with at least two outpatient serum creatinine measurements within a 1-year time period. Validity indices were estimated for CKD using up to 3 years of administrative data (physician billing claims and hospital discharge abstracts) for various case-definition combinations. For each algorithm, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated against two reference standard definitions of CKD (two eGFR measurements <60 mL/min/1.73m(2) or mean eGFR < 30 mL/min/1.73m(2)).
RESULTS: A total of 321 293 eligible subjects were identified. Irrespective of the algorithm, sensitivities for defining CKD (eGFR < 60 mL/min/1.73m(2)) using administrative codes were low. A case-definition algorithm employing two physician claims or one hospitalization within a 2-year period had sensitivity of 19.4%, specificity of 97.2%, PPV of 60.1% and NPV of 84.8% for detecting CKD. Estimates of sensitivity were higher when <30 mL/min/1.73m(2) was used as the reference standard, although PPVs were lower and consistently less than 50%.
CONCLUSION: These results, using eGFR as a reference standard, suggest that administrative data have insufficient sensitivity and PPV for CKD surveillance, although they may be useful when highly specific algorithms are required for research purposes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015442     DOI: 10.1093/ndt/gfr598

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  42 in total

1.  Acute kidney injury in critically ill children and 5-year hypertension.

Authors:  Erin Hessey; Sylvie Perreault; Louise Roy; Marc Dorais; Susan Samuel; Véronique Phan; Jean-Philippe Lafrance; Michael Zappitelli
Journal:  Pediatr Nephrol       Date:  2020-03-11       Impact factor: 3.714

2.  Evidence-Based Decision Making 6: Administrative Databases as Secondary Data Source for Epidemiologic and Health Service Research.

Authors:  Tanvir Turin Chowdhury; Brenda R Hemmelgarn
Journal:  Methods Mol Biol       Date:  2021

3.  Prevalence and recognition of chronic kidney disease in Stockholm healthcare.

Authors:  Alessandro Gasparini; Marie Evans; Josef Coresh; Morgan E Grams; Olof Norin; Abdul R Qureshi; Björn Runesson; Peter Barany; Johan Ärnlöv; Tomas Jernberg; Björn Wettermark; Carl G Elinder; Juan-Jesüs Carrero
Journal:  Nephrol Dial Transplant       Date:  2016-10-13       Impact factor: 5.992

Review 4.  Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.

Authors:  Vaibhav Keskar; Manish M Sood
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-25       Impact factor: 8.237

5.  Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.

Authors:  Haesuk Park; Ghadeer K Dawwas; Xinyue Liu; Mindie H Nguyen
Journal:  J Intern Med       Date:  2019-08-23       Impact factor: 8.989

6.  Identification of incident CKD stage 3 in research studies.

Authors:  Morgan E Grams; Casey M Rebholz; Blaithin McMahon; Seamus Whelton; Shoshana H Ballew; Elizabeth Selvin; Lisa Wruck; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2014-04-13       Impact factor: 8.860

7.  Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.

Authors:  Gregory A Nichols; Anastasia Ustyugova; Anouk Déruaz-Luyet; Maureen O'Keeffe-Rosetti; Kimberly G Brodovicz
Journal:  J Am Soc Nephrol       Date:  2020-06-02       Impact factor: 10.121

8.  Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.

Authors:  Gang Fang; Izabela E Annis; Joel F Farley; Nirosha Mahendraratnam; Ryan P Hickson; Til Stürmer; Jennifer G Robinson
Journal:  Pharmacotherapy       Date:  2017-12-11       Impact factor: 4.705

9.  Determination of the optimal case definition for the diagnosis of end-stage renal disease from administrative claims data in Manitoba, Canada.

Authors:  Paul Komenda; Nancy Yu; Stella Leung; Keevin Bernstein; James Blanchard; Manish Sood; Claudio Rigatto; Navdeep Tangri
Journal:  CMAJ Open       Date:  2015-07-17

10.  Adapting electronic health records-derived phenotypes to claims data: Lessons learned in using limited clinical data for phenotyping.

Authors:  Anna Ostropolets; Christian Reich; Patrick Ryan; Ning Shang; George Hripcsak; Chunhua Weng
Journal:  J Biomed Inform       Date:  2019-12-19       Impact factor: 6.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.